ClotCare: Blood Clots, Stroke, Heart Attack
Saturday, November 23, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

Postings on Acute Myocardial Infarction

Postings for Patients & Caregivers Date Posted
Should We Stop Using Aspirin to Prevent a First Heart Attack or Stroke? December 2018
Should We Stop Using Aspirin to Prevent a First Heart Attack or Stroke? December 2018
Is it Time to Tailor the Dose of Aspirin for Primary Prevention of Cardiovascular Events and Cancer? [Or…Why I changed my aspirin dosing schedule] August 2018
Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future? September 2017
Testosterone Supplements and Blood Clots; an Invitation to Participate in a Research Project December 2014
Dabigatran (Pradaxa) Should NOT be used in Mechanical Heart Valve Patients January 2013
Dabigatran Demystified What Warfarin Patients Should Know About this New February 2012
Plavix & Prilosec Interaction: An FDA Alert & Questions Regarding Clinica March 2010
FDA Approves Effient (prasugrel) to Reduce the Risk of Heart Attack in An July 2009
Prasugrel Approved in Europe February 2009
Controversy Surrounds FDA Panel's Unanimous Vote to Approve New Antiplate February 2009
Clotting Disorders Presentation by Stephan Moll, MD February 2007
Heart attack and stroke protection of aspirin blocked by Ibuprofen and si September 2006
Where can I find an anticoagulation expert near my home or office? October 2005
Bextra Pulled from Market & Warnings Added to ALL NSAIDs April 2005
FDA Rejects Ximelagatran (brand name Exanta) October 2004
News on Vioxx and Congressional Hearings October 2004

Postings for Healthcare Providers Date Posted
Should We Stop Using Aspirin to Prevent a First Heart Attack or Stroke? December 2018
Should We Stop Using Aspirin to Prevent a First Heart Attack or Stroke? December 2018
Is it Time to Tailor the Dose of Aspirin for Primary Prevention of Cardiovascular Events and Cancer? [Or…Why I changed my aspirin dosing schedule] August 2018
Rivaroxaban or Warfarin in Stable Coronary Artery Disease – Should the COMPASS Study Lead Us Back to the Future? September 2017
Testosterone Supplements and Blood Clots; an Invitation to Participate in a Research Project December 2014
A Summary and Update on Combining Antiplatelet Agents and/or Oral Anticoagulants February 2014
Stable Ischemic Heart Disease (SIHD) Guidelines Published June 2013
2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction January 2013
Dabigatran (Pradaxa) Should NOT be used in Mechanical Heart Valve Patients January 2013
Unstable Angina/Non-ST-Elevation Myocardial Infarction: Updated Guideline July 2012
New Chest Guidelines Available Now February 2012
Clopidogrel and PPI use Consensus Report from the ACC Foundation, the ACG December 2010
SPIRIT IV: Everolimus (XIENCE V®) drug eluting stent (DES) may be superio November 2010
FDA Recommends Dabigatran Approval: Agree with no ASA, still skeptical on October 2010
Medication Errors in Cardiovascular & Stroke Patients June 2010
Study Finds Re-hospitalization for MI Increased Two-fold with PPI and Clo June 2010
Plavix & Prilosec Interaction: An FDA Alert & Questions Regarding Clinica March 2010
Low-dose Aspirin therapy - Do the benefits outweigh the risks for people October 2009
Expert Presentations on Atherothrombosis and Plaque Rupture, Pulmonary Em August 2009
FDA Approves Effient (prasugrel) to Reduce the Risk of Heart Attack in An July 2009
Reduction in cardiovascular events with Rosuvastatin correlates with hsCR June 2009
Aspirin for Primary Prevention of Strokes and Heart Attacks April 2009
Prasugrel Approved in Europe February 2009
Controversy Surrounds FDA Panel's Unanimous Vote to Approve New Antiplate February 2009
Clopidogrel Resistance: Effect on Outcomes, Genetic Causes, How to Test f December 2008
Extensive review of the role of platelets in various clinical conditions February 2008
Heart attack and stroke risks are increased in those with deep vein throm January 2008
Can better INR control be achieved, and if so, how will new anticoagulant March 2007
Science Advisory Advocates Dual Antiplatelet Therapy with Aspirin and Thi February 2007
Heart attack and stroke protection of aspirin blocked by Ibuprofen and si September 2006
Clopidogrel plus aspirin possibly harmful in a broad population with card June 2006
Homocysteine Lowering Therapy in Vascular Disease - No Reduction in Recur May 2006
Risk and Benefits of Aspirin in Primary Prevention in Both Men and Women January 2006
Where can I find an anticoagulation expert near my home or office? October 2005
Aspirin Resistance: Do we have standardized methods for measurement? September 2005
Warfarin and Aspirin Combination in Acute Coronary Syndrome August 2005
Aspirin Discontinuation Perioperatively Increases Cardiovascular Events June 2005
What is the best loading dose of clopidogrel for patients undergoing perc May 2005
The Role of Clopidogrel in ST-segment Elevation Acute Coronary Syndrome A May 2005
Bextra Pulled from Market & Warnings Added to ALL NSAIDs April 2005
New Data on Aspirin vs. Warfarin in TIA Patients, but Questions Persist March 2005
What Happened to Ximelagatran? March 2005
Should Rofecoxib (Vioxx) Have Been Withdrawn Years Ago? November 2004
FDA Rejects Ximelagatran (brand name Exanta) October 2004
News on Vioxx and Congressional Hearings October 2004
Pulmonary Embolism Following Coronary Artery Bypass Grafting Surgery October 2004
Exanta not Recommended by FDA Advisory Panel, Causes M.I.s? September 2004
New Supplement Devoted to Unfractionated Heparin August 2004
Genetic Predisposition to Arterial Thrombosis in SLE August 2004
Enoxaparin Found to be Superior to Unfractionated Heparin in Acute Corona August 2004
Clopidogrel Resistance Associated with Increased Heart Attack Risk July 2004
How Long Should Plavix be Used After Coronary Stenting? April 2004

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.
ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.
Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Saturday, November 23, 2024